DANYELLE SMITH: Open Payments
NPI 1528611522 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 16 payments from 7 companies in 2025. Trend: 2023 $252 · 2024 $170 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $139 |
| GENZYME CORPORATION | 2 | $119 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $73 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Organon LLC | 1 | $6 |
Products named: DUPIXENT, NEFFY, XOLAIR, Rhapsido, NUCALA, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
